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                                        INTRODUCTION 
Blood has been used as a life saving product since the seventeenth century when 
the first  blood transfusions were recorded. A large percentage of blood is administered 
to patients during surgery and it is usually  homologous blood. Blood is a tissue and so 
blood transfusion like tissue transplantation carries complications. The non-availability 
of blood and blood products due to shortage of homologous blood is a limiting factor for 
surgery.
With  the  aim of  providing maximum benefit  and avoiding risks  to  patients  a 
number of alternative techniques to homologous blood transfusion have been evolved.
Autologous blood transfusion is the most efficient among the alternative methods 
available. There are four types of Autologous blood transfusion
                    1. Preoperative Blood Donation
                    2. Acute Normovolemic Hemodilution
                    3. Acute Hypervolemic Hemodilution
                    4. Intraoperative &Postoperative Blood salvage
Patients can tolerate anemia with hematocrit of 25-30% as long as normovolemia 
is  maintained.This  forms  the  basis  for  Acute  Normovolemic  Hemodilution.This 
technique involves removal of  predetermined quantity of blood from the patient before 
or after induction of anaesthesia and maintaining isovolemic status with crystalloids or 
colloids .The blood withdrawn is returned to the patient after obtaining near normal 
hemostasis in the surgical field.
             Acute  normovolemic  Hemodilution  is safe, simpler, cost effective than other 
methods  of autologous  transfusion and is an effective strategy to replace homologous 
blood requirement. The surgeon and the anaesthesiologist play a key role in choosing 
their patients and adapting this technique to extract the maximum benefit out of it.
                                           
                                                                  AIM OF STUDY  
The aim of dissertation is to study the safety, hemodynamic alterations  associated 
with  Acute  Normovolemic  Hemodilution  in  patients  undergoing   elective 
gynaecological surgeries with special references to cost effectiveness, time factor and 
complications.
HISTORICAL REVIEW
In  1665,  the  first  recorded  successful  blood  transfusion  occurs  in  England: 
Physician Richard Lower keeps dogs alive by transfusing blood from other dogs.
In 1795, American Physician, Philip Syng Physick, claims to perform the first 
human blood transfusion, although he doesn’t publish this information.
The first instance of  Autologous blood transfusion in man occurred in 1818 when 
BLUNDELL reinfused salvaged blood in to women with post  partum haemorrhage. 
This was prior to discovery of bloodgroups and even allotransfusion.
In  1886,  DUNCAN described  a  case  of  intraoperative  blood  salvage  during 
lowerlimb amputations.  Subsequently  in  addition to  methods of  intraoperative blood 
salvage other methods were developed for the reinfusion of autologous  blood removed 
during weeks prior to operation.
This practice  was first  described by  GRANT in 1921 in patients  undergoing 
surgery for cerebral tumour.
Blood salvage was first reported in American literature in 1917. By 1936, 277 
cases  were  reported.  Sporadic  reports  of  use  of  the  technique  in  patients  with 
hemothorax appeared in the surgical literature from 1931 through the early 1970s. 
In 1966, Symbas  undertook a series of laboratory & clinical studies  leading to 
adoption of an  autotransfusion  protocol  for managing patients with acute traumatic 
hemothorax. This was employed in more than 400 patients between  1966 & 1978. 
In 1968, a method of predonation by means of repeated  donations within a 10 day 
period the so called “Leap Frog method” was developed through which a number  of 
autologous units of blood could be acquired and used in the perioperative period. 
Later blood was removed prior to surgery and the  volume restored by infusion of 
colloids & crystalloids to produce intentional normovolemic hemodilution. This method 
represented an extension to the other surgical  specialities of a technique initially used in 
heart surgery in the course of extra corporeal circulation. In those days it was thought 
that anemia caused by  blood loss should be corrected to so called physiological  values.
In  1970,  the  group  of  MESSMER&  SUNDER  PLASSMANN came  to  an 
entirely different conclusion they depicted that Normovolemic Hemodilution increased 
perfusion & oxygenation of tissues through a change in blood flow  properties based on 
a decrease in blood viscosity. 
Normovolemic Hemodilution was introduced in to surgical practice in 1973 as an 
alternative to transfusion of  homologous blood. Since then it has been in use in various 
surgical fields  were it has been proved as an efficient  blood  salvage procedure. 
REVIEW OF LITERATURE
H.HINT (1968)  19 postulated that  a  reduction in hematocrit  is  not  necessarily 
followed by a decrease in O2 transport.
SUNDER – PLASSMANN(1971) in their experimental data found that the O2 
transport is at its maximum  when the hematocrit is between 25-30% i.e. well below the 
physiological values.
ROBERT  PILON  et  al(1973)  29 studied  the  effects  of  acute  normovolemic 
hemodilution  on  hemodynamics  ,  oxygen  transport,  tissue  perfusion  &  blood 
volume.Patients  undergoing  total  hip  replacement  were  chosen  and  hematocrit  was 
reduced to 29%and 21% by bleeding in two steps.The major compensation observed 
was a rise in cardiac output to 123% and 136% respectively.
K.MESSMER  (1975)  22 studied  hematocrit-viscosity  relationship  at  different 
shear rates of blood flow. Linear changes in hematocrit are followed by disproportional 
increments or decrements in blood viscosity.A decrease in hematocrit from 40% to 20% 
decreases viscosity by 50% in both arteries & veins.
SALMA ZAFAR et al 30 in their study of intraoperative hemodilution carried on 
in patients undergoing major elective surgery concluded that the method was safe & 
requirement of homologous blood was reduced by another 90%.
W.P.KLOEVEKORN  et  al(1974) demonstrated  that  in  ANH  the  increased 
venous return and decreased afterload resulting from the decrease of viscosity cause an 
increase in cardiac output without significant changes in heart rate.
D.ROSE et al (1979) 12 in their study of ANH in major cancer surgeries had noted 
an  increase  in  cardiac  output  with  no  changes  in  mean  arterial  pressure.During  the 
procedure no changes in electrolyte values or clotting factors was noticed.
EIKE MARTIN et al (1987)  14 concluded that intraoperative and preoperative 
dilution can be well tolerated up to a  hematocrit of 25% under a constant  circulating 
normovolemic  volume.
 AUDIBERT,G.DONNER.M.et al (1993)  3 compared the influence of various 
plasma substitutes administered for preoperative hemodilution on blood rheology..He 
studied  4%  albumin,  35%dextran   40%gelatin,  and  HES  after  hemodilution  to 
hematocrit of 30%.Erythrocyte aggregation markedly decreased in albumin and dextran, 
unchanged  in  HES,increased  in  gelatin.  They  suggested  albumin  and  dextran  40  as 
plasma substitutes of choice for ANH, when this technique aims to improve rheological 
conditions.
OBERHAUSER et al (1996)  27 in their clinical trial  on Acute Normovolemic 
Hemodilution on patients undergoing major gynaecological operations found that ANH 
was  a  safe,  easy  to  handle  procedure  .  No  ischemic  events  or  perioperative 
complications were observed.It was an effective procedure to avoid homologous blood 
transfusion.
C.F.HOGMAN  F  et  al  (1999)  20 studied  the  stored  whole  blood  before 
transfusion and the effect of temperature on RBC 2,3 DPG .When blood was stored at 
30oC  2,3DPG  concentration  decreased  from 858±106  to  316±172mmol/molecule  of 
hemoglobin(63%decreased), 99% was lost  within 8 hours. No loss of 2,3 DPG was 
observed at 4oC and 10oC storage. No difference was attributable to the anticoagulant 
used.
HETTEROGODS  et  al(1997)  18 carried  out  ANH  in  patients  undergoing 
Coronary artery bypass grafting.They had analysed the effects of ANH in maintaining 
O2 perfusion and changes in ECG noticed during the procedure. They demonstrated that 
there was no ST segment changes among the patients undergoing hemodilution.
MIRHASEMI et al (1999)  25 carried out a study of  intraoperative autologous 
blood transfusion on patients undergoing  Type 3 Radical hysterectomy. Their procedure 
was  one  of  the  moderate  ANH.  Isovolemic  hemodilution  brought  about  significant 
reduction in transfusion and they observed that recurrence of tumour metastasis was less 
among the study group.
J.L.CARLSON et al (1999)  6 studied the risk of bacterial infection associated 
with allogenic blood transfusion in patients undergoing hip fracture repair .There was a 
35% greater risk of serious bacterial infection and 52% greater risk of pneumonia.
FERRARIO  CARLIS  M  (1995)  studied  the  mechanism  of  systemic 
vasodilatation during normovolemic hemodilution. They concluded that neural reflexes 
do not modulate systemic vascular response to hemodilution. Nitric oxide (EDRF) is the 
most likely cause of systemic vasodilatation in ANH.
GOODNOUGH  LT et al (2000)23 in their randomized trial compared ANH and 
preoperative autologous blood donation  in hip arthroplasty. ANH was safe and was less 
costly than preoperative blood donation.(ANH:US $151±154) PABD (US $680±253) 
respectively  .ANH  was  equivalent  to  PABD  in  effectively  reducing  exposure  to 
allogenic RBC s.
LISANDER et al (1996)23 of Sweden used the technique of ANH on patients 
undergoing  spinal  surgery.  1150  ml  was  shed  from the  patients  and  normovolemia 
maintained. They concluded that ANH was effective in conserving the allogenic blood 
resources.
ACUTE NORMOVOLEMIC  HEMODILUTION
DEFINITION :
Acute Normovolemic Hemodilution  is defined as the removal of blood from a 
patient  immediately  before  operation  ,either  before  or  shortly  after  induction  of 
anaesthesia and simultaneous replacement with an appropriate volume of crystalloids or 
colloid, alone or in combination, such as to maintain the circulating volume.
ANH  as  a  blood conservation  strategy :
ANH  is  one  among  the  many  options  available  to  clinicians  to  minimize 
perioperative exposure to allogenic blood products.The volume of blood conserved is 
directly proportional to the differences between the  original and postdilution hematocrit 
values.The only blood conservation technique that  results  in  fresh whole autologous 
blood  is  ANH  and  it  is  endorsed  by  the  National  Institutes  of  Health  Consensus 
Conference  on  Perioperative  Red  Blood  Cell  Transfusion  and  American  Society  of 
Anesthesiologists.This accessible and easily institutable technique should be considered 
for all surgical patients, although its suitability and efficacy will depend on the clinical 
situation.
In 1972, a study found that  until  a hematocrit  value of 30% was reached ,the 
decreased viscosity and the increased cardiac output (C.O) provided maintenance  of a 
maximal oxygen delivery to the tissues  during  hemodilution. Further studies on the 
rheological, hemodynamic, metabolic and cardiovascular consequences of hemorrhagic 
shock provided additional information .ANH is considered to be a viable alternative to 
transfusion with allogenic blood products and is used since 1970 for surgical patients.
CLASSIFICATION  OF  HEMODILUTION :
Hemodilution  refers to decrease  in  hematocrit  or  hemoglobin concentration as 
a result of  dilution of RBC s (dilutional anemia) . Several  types of  hemodilution have 
been described
(1)Hypervolemic  hemodilution
(2)Hypovolemic    hemodilution and
(3)Normovolemic  hemodilution
Hypervolemic  hemodilution :
A therapeutic decrease in whole blood viscosity occurs with no change in plasma 
viscosity  accompanied   by  an   increase  in  circulating  blood volume .Hypervolemic 
hemodilution  has  been used  with  success  in  patients  with  chronic  occlusive  arterial 
disease  and stroke patients.
Hypovolemic  hemodilution :
During hypovolemic hemodilution if an individual is healthy, no crystalloid or 
colloid is administered during preoperative blood donation.It should be borne in mind 
that  normalization of  blood volume occurs  within 12 to  24 hours  via  compensatory 
physiological  phenomena.
Normovolemic Hemodilution :
Normovolemic  hemodilution  causes  an  intentional  decrease  of  hemoglobin 
concentration  by  withdrawal  of  a  calculated  volume  of  the  patients  blood   and  by 
simultaneous  administration  of  cell  free  substitute,  near  normal  blood  volume  is 
maintained.
The  rationale behind the use of ANH as a method  for blood conservation is that 
if  intraoperative  blood  loss  is  relatively  constant  ,  the  loss  of  blood  constituents 
,especially RBCs  would be reduced if the blood is diluted by a plasma  expander.The 
patient’s own fresh blood is reinfused after  obtaining near normal hemostasis in the 
surgical field i.e. after major blood loss has ceased.
GUIDELINES  FOR  ANH :
PATIENT   SELECTION :
The most critical step deciding the outcome of ANH is proper patient selection. 
The decision  to recommend ANH   for an individual  patient should lie with the surgeon 
and anaesthetist.
AGE :    
The  technique of ANH has no age bar .It has been employed in paediatric as well 
as  elderly  patients.  But  one  should  be  cautious  of  the  complications  related  to 
unsuspected atheromatous disease as age advances.
HEMOGLOBIN  STATUS :  
Preoperative Hb of the patient should be >11gm/dl.
BLOOD  LOSS  :  
ANH  is considered in surgeries where blood loss is likely to be greater than 20% 
of blood volume. It is suitable for Elective as well as Emergency procedures.
MEDICAL  DISORDERS : 
Patients with cardiac, pulmonary, renal, and liver disorders cannot tolerate ANH.
JEHOVAH’S WITNESS : 
Some members of Jehovah’s witness faith will agree to hemodilution if the blood 
is maintained in a closed circuit continuous flow system.
SCREENING : 
Patients need not  be routinely screened for viral markers.Universal precautions to 
protect staff from the risks of virus transmission must always be observed.
CONTRAINDICATIONS :
ANEMIA :   
It is a major contraindication to hemodilution.It is inappropriate to employ this 
technique when the Hb is less than 11gm/dl.
CARDIAC DISEASE : 
Patients with cardiac dysfunction undergoing noncardiac surgery are not suitable 
candidates.  Because  an  increase   in  cardiac  output  may  neither  be  possible  nor 
desirable.The technique can however be used during cardiac surgery because pump flow 
can be altered to compensate for volume changes.
PULMONARY DISEASE :
Pulmonary dysfunction which impairs oxygenation of blood are contraindications 
to ANH.
RENAL DYSFUNCTION : 
Impaired renal function interferes with the excretion of  diluent fluids. This results 
in pulmonary edema.
LIVER  DISORDER : 
Hepatic dysfunction is associated with low levels of clotting factors and during 
hemodilution the factor levels might decrease below critical levels thus predisposing the 
patient to hemorrhage.
HEMOSTATIC  DISORDERS :
Hemodilution might lead to decrease in clotting factor levels below critical limits 
leading to hemorrhagic complications.
ADVANTAGES OF ANH :
 Blood returned to the patient contains functional red cells,clotting factors 
and platelets. 
 Red blood cell loss is decreased when ANH is employed.
 Eliminates the risk of transfusion reactions, transfer of infectious disease, 
immunomodulatory effects.
 Provides a safe means of transfusion in patients with multiple antibodies.
 Patients with rare blood group can undergo surgery utilizing this technique.
 ANH leads to improved tissue perfusion and oxygen delivery which may be 
most  important  in  patients  with  peripheral  vascular  and  cerebrovascular 
disease.
 Hemodilution as a ‘point of care strategy’ in the operating room obviates 
the need for blood bank facilities.
 Obviates the need for blood screening, storage and crossmatching.
 Blood  drawn   during  ANH  doesn’t    undergo  biochemical  alterations 
associated with stored bank blood.
 Avoids  the  risk  of  clerical  error  ,  mistransfusion  and  bacterial 
contamination.
 The presence of malignancy may contraindicate the use of intraoperative 
blood salvage but not ANH.
 Some patients  of  Jehovah’s  witness  agree  to  ANH as  long  as  blood  is 
maintained in a close circuit system.
 ANH  is  a  cost  effective  blood  conservation  technique  that  reduces  the 
demand on homologous blood.
 Gives  patient  the  psychological  benefit  of  actively  participating  in  their 
treatment.
COMPLICATIONS :
Hemodynamic imbalance : 
Blood withdrawal and administration of diluent fluids should parallel each other 
to  maintain  normovolemia.Excess  of  fluids  lead  to  pulmonary  edema  whereas 
underfilling leads to hypovolemia.
Myocardial Ischemia : 
This is a potential complication of ANH.Elderly patients who often have a silent 
atheromatous disease are more prone.In these patients  the augmented cardiac output 
increases myocardial O2 consumption whereas oxygen content  of  the  blood  supplying 
the  myocardium  is inadequate.
Coagulopathy :
        Coagulopathy related to dilution of clotting factors and increased bleeding due to 
enhanced capillary blood  flow are proposed to be complications of ANH  ; however 
experience suggests that these are theoretical  rather  than  clinical  problems.
PLASMA  SUBSTITUTES USED IN ANH :
During  Acute  Normovolemic  Hemodilution  crystalloids,  colloids  and 
combinations of both have been used as diluents to maintain normovolemia.The most 
common crystalloid used is Lactated Ringers solution .A number of colloids are in use 
including hydroxy ethyl starch Gelofusine ,Dextran, 3%polygeline  and  natural  colloid 
albumin.
Crystalloids vs Colloids :
     The advantage of crystalloids is that they are cheaper,lack the adverse reactions 
associated with colloids.But the principle shortcoming is their tendency to traverse the 
vascular endothelium and leave the vascular compartment .When they are used as sole 
replacement fluids they should be  administerd  in  a   3:1 ratio to  that  of  blood 
withdrawn.
         Colloids  on  the  other  hand  are  retained  longer  in  the  circulation,thereby 
maintaining  colloid  osmotic  pressure  and  plasma  volume  for  several  hours;hence 
inferring   that  crystalloids  have  a  greater  tendency  to  cause  pulmonary  edema than 
colloids.But  the  amount  of  fluid  administered  and  the  vigilance  in  monitoring  the 
hemodynamic variables are more important in the development of pulmonary edema 
than the choice of the fluid.
COMPARISION  BETWEEN  DILUENT FLUIDS  USED.
CRYSTALLOID COLLOID
Volume required 3 times volume of shed 
blood
1-2 times volume of 
shed blood
Plasma volume 80% leaves intravascular 
compartment in 2 hours
Retains longer in the 
circulation- a better 
plasma expander.
Colloid osmotic 
pressure 
Reduced Maintained
Chance of 
edema
More chance of peripheral 
and Pulmonary edema
Less chance
Postoperative 
Hematocrit
Higher Lower
Coagulation 
defect
None May occur with 
excessive colloids 
(Dextran)
Cost Cheaper Expensive
PHYSIOLOGICAL  CHANGES ASSOCIATED WITH  ANH:
Effects on Blood viscosity and flow resistance:
Hemodilution brings about a decrease in blood viscosity. This is achieved mainly 
through reduction in the hematocrit. The formation of red cell aggregates is hampered 
and the rouleaux formation are less stable,therefore becomes easily disaggregated, thus 
the viscosity of blood is reduced.
         The decrease in blood viscosity has graded effects at different levels of vascular 
compartment  which in  turn is  related to the shear  conditions.  The most  pronounced 
decrease of blood viscosity occurs within the post capillary venules when the hematocrit 
is decreased to approximately 25-30%.Acute reductions in hematocrit reduce the viscous 
resistance  which  in  turn  decreases  the resistance  to  flow,  especially  within the  post 
capillary venules, resulting in an increase in venous return.
Guyton  and  Richardson  were  able  to  prove  that  venous  return  increases 
significantly when the hematocrit is reduced under isovolemic conditions.
Hemodilution  →  Decrease  in  viscosity  →  Lowers  the  flow  resistance
→ Increase in venous return.
EFFECTS ON CARDIAC OUTPUT AND ORGAN BLOOD FLOW:
Under  conditions  of  acutely  induced  normovolemic  hemodilution,  the  linear 
reduction in hematocrit leads to a prompt raise in cardiac output. The increase in venous 
return and decreased peripheral resistance are responsible for the raised cardiac output 
with  the  heart  rate  changing  only  slightly.A  distinct  increase  in  heart  rate  with  a 
relatively small increase in cardiac output per unit hematocrit  decrease is indicative of 
an impeded venous return due to hypovolemia.
        The  reduced  peripheral  resistance  in  addition  to  decreased  viscosity  is  also 
because of reflex vasodilatation or local regulatory factors such as endogenous release of 
Nitric Oxide.
         Increase in venous return + decreased afterload → Increased cardiac output 
→ Maintains O2 transport.
   As first reported by Race and Dedichan, total blood flow to most organs rises in 
direct proportion to the increase in cardiac output. This has been confirmed for cerebral 
blood  flow  to  normal  brain  tissue  as  well  as  to  areas  with  impaired  cerebral 
vasoregulation, for renal blood flow, hepatic arterial and total liver blood flow.
TISSUE OXYGENATION :
Due  to  reduction  in  red  cell  mass  and  thus  the  decrease  in  hemoglobin 
concentration hemodilution necessarily diminishes the oxygen content of blood.
 But the decrease in arterial oxygen content is not translated to decrease in tissue 
oxygenation.Because the following 3 different mechanisms compensate for the decrease 
in oxygen content.
1. Increase in nutritional flow.
2. Enhanced oxygen extraction by the tissues.
3. Shift of oxygen dissociation curve to the right.
NUTRITIONAL  FLOW :  
Hemodilution  leads to a decrease in blood viscosity which in turn maintains a 
more homogenous distribution of microcirculatory flow.Tissue nutritional flow has been 
investigated in resting skeletal muscles.Gaethgens et al in their study on the effect of 
normovolemic  hemodilution  on  skeletal  muscle  during  enhanced  metabolic  activity 
observed  that  the  increase  in  nutritional  flow  is  sufficient  to  compensate  for  the 
reduction in oxygen content. ANH improves the nutritional flow to the tissues which is 
apparent from tissue pO2 measurements.
OXYGEN EXTRACTION :
The  maintainence  of  normal  tissue  oxygenation  during  limited  hemodilution 
originates from the well developed red cell flux per time unit even though the number of 
red cells per unit blood is reduced.Local oxygen supply to the tissues is not impaired by 
limited normovolemic hemodilution but,in contrast becomes more homogenous.
          The second mechanism that maintains adequate  oxygenation is the increase in 
oxygen extraction by the tissues .The mechanism  is  utilized as soon as the oxygen 
demand is increased and also whenever hypovolemia comes into play.
Buckberg  could  demonstrate  that  oxygen  delivery  to  the  entire  left  ventricle 
remains adequate over a wide range of hemoglobin levels,He analysed the myocardial 
blood flow distribution by means of radioactive microspheres during ANH.
DECREASE IN OXYGEN AFFINITY :
The predominant adaptational mechanism for the acute decrease in blood oxygen 
content during acute normovolemic hemodilution is an increase in cardiac output and 
nutritional flow to various organs. But the decrease in oxygen affinity of hemoglobin 
facilitates oxygen release at the tissue level.There is a linear correlation between affinity 
changes and the intraerythrocytic 2,3 DPG concentration.
Therefore  from the  above  discussion  we  conclude  that  limited  normovolemic 
hemodilution doesn’t  jeopardize the tissue oxygen supply as  it  is  maintained by the 
physiological compensatory mechanisms. 
PROCEDURE DESCRIPTION OF ANH
ANH is characterized as either moderate or severe hemodilution, depending on 
whether the hematocrit is 25-30% (moderate or limited) or 15-20% (severe or extreme). 
ANH involves the active withdrawal of the patients blood and the temporary acceptance 
of  a  lower  hemoglobin.  The  collected  blood is  temporarily  stored  and  subsequently 
transfused to the patient as indicated.
Before  the  withdrawal  of  blood,  adequate  intravenous  access  is  necessary.  A 
urinary catheter, pulse oximeter for continuous monitoring of hemoglobin saturation and 
ECG monitor should be in place. Some authors have advocated the use of a central 
venous  catheter  or  pulmonary  artery  catheter  for  assessing  ventricular,  filling  or 
approximating the adequacy of tissue oxygenation.
Blood is withdrawn from a peripheral vein where an automated blood pressure 
cuff  may  facilitate  collection.  Blood  drains  into  standard  blood  collection  bags 
containing an anticoagulant such as Acid citrate dextrose or citrate phosphate  dextrose.
The collection of fresh whole blood should require above 10 minutes per unit. 
Strict adherence to sterile technique should be maintained. The blood should not leave 
the operating room so that there is little chance of administering it to the wrong patient, 
The blood should remain at room temperature in the operating room; if removed from 
the operating room, it must be appropriately labelled and stored at 4-6°C. The blood 
should be re-administered in reverse order of collection, a method that ensures that the 
most  hemodiluted  unit  is  given first  and the one with the most clotting factors and 
RBCs will be given last.
There are several formulas to guide the process of withdrawing the predetermined 
amount of blood:
V = EBV X Hcti - Hctf / average Hct,
Where the average Hct = (Hcti - Hctf )2 + Hctf    where EBV is the estimated 
blood volume,  V is the volume to be collected,  Hcti is the initial Hct, and Hctf is the 
final desired Hcf. An alternate formula that is.an accurate guide to determine the volume 
of  blood to withdraw for ANH is 
V = EBV ((Hcti-Hctf) (3-avgHct)
During  ANH,  large  amounts  of  fluid  are  frequently  necessary  to  maintain 
normovolemia, although the net fluid increase may be insignificant compared with the 
usual  transfusion  requirements.  Complications  associated  with  the  increased  fluid 
include peripheral edema, pulmonary edema, abnormal would healing, and worsened . 
postoperative pulmonary function. Peripheral edema is relatively common with ANH, 
but pulmonary edema is not common. In most patients with good ventricular function, 
the increased fluid is well tolerated and usually resolves in 72 hours. Left ventricular 
hypertrophy or dysfunction is the factor that reduces the tolerance to the increased fluid 
volumes.
Because the withdrawn blood must  be adequately replaced with crystalloid or 
colloid fluid, comparisons have been performed to determine the optimal type of fluid 
replacement for ANH. Although crystalloid alone is acceptable, either colloid alone or a 
combination of crystalloid and colloid is favoured .Albumin, hydroxyethyl starch, and 
dextran are the colloids that have been successfully used for ANH.
Crystalloid is usually given as a 3 to 4-mL replacement per mL of withdrawn 
blood. Colloid is usually given at 1-2 mL per mL of blood withdrawn.
The primary indication for ANH in surgical patients is the reduction of allogeneic 
blood transfusion. Perioperative transfusion of RBC and other blood products have been 
decreased with ANH.  As important, the percentage of patients who do not receive any 
blood products is increased from 13% to 42%, if ANH is combined with other blood 
salvage procedures during cardiac and noncardiac operations.
MATERIALS   AND   METHODS
SETTING   :Institute of Obstetrics and Gynaecology, Egmore, Chennai. 
YEAR OF STUDY : April 2007 -  April 2008
NATURE  OF STUDY  : Prospective study.
 30 patients posted to undergo elective gynaecological surgeries were chartered in 
to the study. Informed consent was obtained from the patients. This study was approved 
by the board of ethical committee.
INCLUSION  CRITERIA :
 Age    :   20 – 60 years
 Preoperative Hb :  > 11 gm/dl
 Hematocrit  :  30%
 Absence of   Cardiac, Pulmonary, Renal, Liver disease 
 Absence  of  uncontrolled  hypertension  and   other  comorbid 
conditions.
 Absence  of  Hemostatic disorders.
 Absence  of  infection
EXCLUSION  CRITERIA  :
 Age    :   <20  or  >60 years
 Anemia :   Hb  < 11 gm/dl
 Hematocrit     <30%
 Untreated  hypertension
 Impaired cardiac, pulmonary, renal ,hepatic function.
 Coagulation disorders
 Hypoalbuminemia.
 Presence of infection
Pre operative evaluation :
1. Patients awaiting elective gynaecological surgery were  evaluated  for anaesthetic 
fitness and criteria to be fulfilled to undergo ANH was analysed.
2. Procedural  details were explained to the patients.
3. Informed consent was obtained from the patients.
INVESTIGATIONS :
Urine     -       Protein
                      Sugar
                      Microscopy
Blood            Hb%
                      PCV
                      Total count
                      Differential count
                      ESR
                      Platelet count.
Blood            Urea
                      Sugar
Serum           creatinine
Serum           Electrolytes  -  Na, K
Serum Proteins
Bleeding time
Clotting  time
Chest X-ray PA view
ECG
Estimation  of   blood  volume  to be collected  during  Acute  Normovolemic 
Hemodilution by using GROSS FORMULA
           Volume of blood to be collected  = EBV * Hct I-Hct f /Hct av 
      EBV   =    Estimated  Blood  Volume
      Hct I   =    Initial hematocrit( preoperative)
      Hct f   =    Final   hematocrit desired after hemodilution.
      Hctav =    Average hematocrit.
Estimated  blood  volume is  about  7% of the patients body weight.
On the day of Surgery :
Patients  were  brought to the theatre  by  around 8.30 am.
Premedication  :
Patients were premedicated with Tab.Diazepam 5mg, Tab.Perinorm 10 mg and 
Tab.Ranitidine 10mg,  the night before surgery.
PREPARATION :
               The following  baseline parameters  were  recorded
1. Pulse rate
2. Systolic  blood pressure
3. Diastolic blood pressure
4. Pulse Oximeter –O2 saturation
5. ECG
6. Urine output –After bladder catheterization
Patients   received   oxygen  5  litres  /min   through  ventimask  during  the 
preinduction phase.
Two  16 G venflon cannula were started aseptically, one on a big forearm vein to 
infuse crystalloid (NS,RL) and colloid (Haemaccel).The other cannula was used as the 
port to withdraw blood  by connecting it to the blood bags. Withdrawal of blood was 
facilitated in some patients via automated blood pressure cuff.
Collection  of  blood :
1. Blood  was  collected  from  the  antecubital  vein  opposite  to  the  upperlimb,  in 
which the intravenous fluids were on flow.
2. Blood  volume  to  be  collected  was  based  on  the  calculation  using  the  Gross 
Formula to perform  moderate hemodilution to achieve a target PCV of 28%.
3. Blood bags used were sterile disposable bags each of 350 ml volume containing 
45ml of Citrate Phosphate Dextrose as an anticoagulant.
4. For each ml of blood removed 3ml of crystalloid or 1ml of colloid (haemaccel) 
were replaced simultaneously through the cannula placed in the opposite forearm 
vein.
5. For the calculated total volume of blood, the first half volume was replaced with 
crystalloids and the second half with colloids.
6. Blood bags were weighed  using a scale graduated to show reading in increments 
of  every  25  gms.  The  volume  of  blood  collected  was  calculated  using  the 
conversion: 1ml of blood is 1.06gms approximately.
7. During the period of blood withdrawal  frequent  manual rocking of blood bags 
were done to allow the blood to mix uniformly with the anticoagulant.
8. After collection of appropriate volume of blood each blood bag was labelled in 
the sequential order of collection. Patients details – Name, Age, IP NO, Date and 
time of collection were written. Bags were kept inside the theatre itself by the side 
of operation site.
9. All the vital signs were monitored during the  process of blood withdrawal.
10.Blood samples were drawn for  estimation of  Hb,PCV,BT,CT,RBC count  after 
each unit of blood withdrawal.
11.Anaesthetic  technique  was  General  anaesthesia  with  controlled  ventilation 
standardized for all patients.
12.Patients  were  induced  with  2.5%  Inj.Thiopentone  sodium  5mg  /kg  IV  and 
intubated with Inj suxamethonium 2mg/kg IV.  They were intubated orotracheally 
with  appropriate  size  endotracheal  tube.Maintainence  of  anaesthesia  was  with 
Nitrous Oxide/Oxygen and Halothane 0.5% .Inj.Vecuronium 4mcg/kg was used 
to  facilitate  intermittent  positive  pressure  ventilation.At   the  end  of  surgery 
patients were reversed with Inj.Neostigmine 50mcg/kg  and Inj. Atropine 20mcg/
kg  slow IV and extubated after full recovery.
13.Intraoperative fluids used were RL,NS & Haemaccel depending on the surgical 
blood loss with the aim of maintaining stable hemodynamics.
14.Blood  that  was  withdrawn  was  administered  after  achieving  near  complete 
hemostasis  at  the  end  of  surgery  i.e.  after  major  blood  loss  has  ceased  or  if 
intraoperative hemoglobin was less than 8gm/dl
15.Blood was transfused in the reverse order of collection.
16.Vital parameters were monitored throughout the intraoperative period.
17.Blood  samples  were  withdrawn  for  estimating  Hb,PCV,RBC  count,Bleeding 
time  ,clotting  time  both  before  transfusion  and after   transfusion  of  collected 
blood.
18.After complete recovery patients were observed in the post operative Intensive 
Care Unit for 24 hours and then shifted to postoperative wards.
19.Patients were followed up till discharge. 
OBSERVATION  AND  RESULTS
A group of 30 patients undergoing elective gynaecological  surgery were selected 
for the study and they underwent acute moderate normovolemic hemodilution.
DEMOGRAPHIC   PROFILE  
TABLE  1   
AGE DISTRIBUTION
AGE in years    ANH  n=30
25-29 3   (10%)
30-34 8   (26.6%)
35-39 10 (33.3%)
40-44 5   (16.6%)
45-49 2   (6.6%)
50-54 2   (6.6%)
In  our  study  majority  of  patients  belonged  to  35-39  year  age  group   about 
33.3%.26.6% patients were in 30-34 year age group. About 16.6% patients belonged to 
40-44 year age group.10% patients were in 25-29 year age group .6.6% of patients were 
there in 45-49 year age group and another  6.6% were in 50-54 year age group .
TABLE 2    
WEIGHT  DISTRIBUTION
Weight in kg         ANH     n=30
50-54 6 (20%)
55-59 11(36.6%)
60-64 8 (26.6%)
65-69 4 (13.3%)
70-74 1 (3.3%)
             
In our study majority of patients were  in the weight distribution group 55-59 kg 
(36.6%).  8  (26.6%)  patients  weighed  between  60-64  kg.6  (20%)  patients  weighed 
between  50-54kg.  4  (13.3%)  patients  weighed  between  65-69kg.  1  (3.3%)   patient 
weighed between 70-74 kg.
Table 3
BLOOD COLLECTION AND STATISTICAL  DATA
ANH
N=30
Initial
Hb
gm/dl
Initial
Hematocrit
%
Target 
Hematocrit
%
Maximum 
volume of blood 
that can be 
withdrawn (ml)
Volume of 
blood 
collected (ml)
Colloid 
replaced 
(ml)
Crystalloid 
replaced 
(ml)
Average 12.16 36.25 28% 803 780 508 1207
The  average Hb level of patients who entered our study was 12.16 gm/dl, the average Hematocrit  was 36.25%. 
The target hematocrit aimed to be achieved after hemodilution was 28%. The maximum volume of blood that could be 
withdrawn was 803 ml. The average volume of blood collected was 780ml. Average volume of colloid replaced was 
508ml and crystalloid replaced was 1207 ml on an average.
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Table 4
TIME  DURATION  FOR HEMODILUTION
ANH
N=30
Average volume of blood 
collected (ml)
Start time of ANH 
(a.m.)
Finish time of 
ANH (a.m.)
Total duration of 
ANH (minutes)
Average 780 9.05 9.50 45
The average time taken for withdrawal of 780ml of blood was 45 minutes. 
Therefore to withdraw one bag of 350ml of blood time taken was 20.1 minutes.
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HEMODYNAMIC  PARAMETERS  AT VARIOUS STAGES OF 
ACUTE NORMOVOLEMIC HEMODILUTION
TABLE  5
HEART RATE CHANGES DURING ANH
Stage of 
ANH
Pre 
Hemodilution
Post 
Hemodilution
Pre 
Transfusion
Post 
Transfusion
Heart Rate 77.4 ± -5 78 ± 5 79.2± 5 79.6 ± 4
Heart rate changes were as follows :
Heart rate during the pre hemodilution period  was 77.4 ±  5 beats/
min , in the post hemodilution phase it was 78 ± 5/min. In pretransfusion 
phase  heart rate was 79.2 ±5 / min and  79.6 ± 4/min in post transfusion 
phase.
45
TABLE  6
HEART RATE CHANGES DURING ANH
         
Parameter Stages of ANH compared
Mean 
change
P value
Pre hemodilution vs post 
hemodilution
1 0.60  NS
HEART 
RATE
Prehemodilution vs pretransfusion 2
0.16  NS
Prehemodilution vs post 
transfusion
2
0.09  NS
NS:Non Significant
The  mean change in heart rate during various stages of ANH was 
1 or 2 beats/min .Statistical analysis  have shown that the changes in heart 
rate during various stages of ANH was insignificant with p value >0.05.
TABLE 7
BLOOD PRESSURE CHANGES IN ANH
Parameter Pre Post Pre Post 
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Hemodilution Hemodilution Transfusion Transfusion
SBP 123.67±6 124±0.8 121.87±4 123.87±6
DBP 77.93±3 78±0.6 77±5 78.3±4
MAP 94.7±6 93.3±5 92.57±0.8 94.2±5
The blood pressure parameters during various phases of ANH are: 
Prehemodilution systolic BP 123.67±6mm Hg,in posthemodilution period 
it was 124 ±0.8 mm Hg , pretransfusion value was 121.8 ± 4 mm Hg, 
during  posttransfusion  period it was 123.87 ± 6 mm Hg.
Diastolic  BP variations  during  ANH were  77.93  ±  3mmHg  in 
prehemodilution  phase,  78  ±  0.6mmHg  in  posthemodilution  phase, 
During  pretransfusion  period  it  was   77±5 mm Hg ;  post  transfusion 
diastolic BP was 78.3 ± 4.
The changes in Mean Arterial pressure were 94.7 ±6 mm Hg in pre 
hemodilution phase, 93..3±5 mm Hg in posthemodilution period , 92.57 
±0.8 mm Hg in the pre transfusion period, 94.2±5 mm Hg in the post 
transfusion period.
TABLE  8
CHANGES IN SYSTOLIC BLOOD PRESSURE
Parameter Stages of ANH compared Mean P-value
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change
Prehemodilution vs 
posthemodilution
0.33 0.12  NS
Systolic Blood 
Pressure
Prehemodilution vs 
pretransfusion
1.8 0.41   NS
Prehemodilution vs post 
transfusion
0.2 0.62   NS
NS:Non Significant
Table 8 shows the mean change and test of significance of systolic 
blood pressure between various stages of ANH. The changes in systolic 
blood  pressure  during  different  phases  of  the  ANH  procedure  were 
statistically insignificant  with  P value >0.05
TABLE   9
CHANGES  IN DIASTOLIC  BLOOD  PRESSURE
Parameter Stages  of  ANH  compared
Mean 
change
P-value
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Prehemodilution  vs 
posthemodilution
-0.07 0.25 NS
Diastolic blood 
pressure
Prehemodilution vs 
pretransfusion
0.93 0.43NS
Prehemodilution vs 
posttransfusion
0.37 0.12NS
NS:Non Significant
Statistical  analysis  of  the  Diastolic  blood  pressure  variations 
observed during various phases of ANH  showed insignificant changes 
with P value >0.05.
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TABLE  10
CHANGES IN MEAN ARTERIAL PRESSURE
Parameter Stages of ANH compared
Mean 
Change
P value
Mean arterial 
pressure
Prehemodilution vs 
posthemodilution
1.4 0.16  NS
Prehemodilution vs 
pretransfusion
2.13 0.09 NS
Prehemodilution vs 
posttransfusion
0.5 0.52  NS
NS:Non Significant
Table 10 has listed the mean change and test  of significance of 
mean  arterial  pressure  at  various  phases  of  Acute   Normovolemic 
Hemodilution.
     Analysis  of MAP  variation during various stages of ANH showed 
that the changes were statistically insignificant  , P value was >0.05.
TABLE  11
CHANGES  IN  OXYGEN SATURATION DURING  ANH
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Parameter Pre Hemodilution
Post 
Hemodilution
Pre 
Transfusion
Post 
Transfusion
Oxygen 
saturation %
99.5 ± 0.08 99.6 ± 0.4 99.43 ± 6 99.5 ± 0.09
Oxygen saturation during prehemodilution was 99.5 ± 0.08, during 
posthemodilution  it  was  99.6  ±  0.4  ,in  pretransfusion  period  it  was  
99.43 ± 6 and  post transfusion period it was 99.5 ± 0.09.
TABLE  12
CHANGES IN OXYGEN SATURATION
Parameter Stages of ANH compared Mean change P value
Prehemodilution vs posthemodilution 0.1 0.18 NS
O2 
saturation
Prehemodilution vs Pretransfusion 0.07 0.32 NS
Prehemodilution vs posttransfusion 0 0.21 NS
NS:Non Significant
The above table gives the mean change and test of significance of 
oxygen  saturation  at  various  stages  of  Acute  Normovolemic 
Hemodilution.
Statistical  analysis  of  changes  in  O2 saturation  have  shown 
insignificant variation  during various stages of ANH P value  > 0.05.
TABLE  13
CHANGES IN BLEEDING TIME AND CLOTTING TIME
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DURING  ANH
Parameter
Pre 
Hemodilution
Post 
Hemodilution
Pre 
Transfusion
Post 
Transfusion
Bleeding 
time (min)
1.06 ± 0.56 1.74 ± 0.64 1.92 ± 0.46 1.68 ±0.56
Clotting time 
(min)
4.12 ± 0.69 4.74 ± 0.86 5.06 ± 0.04 4.90 ± 0.06
                       
The  bleeding  time  during  different  stages  of  ANH  was 
prehemodilution  1.06  ±  0.16min,  posthemodilution  1.74  ±  0.04  min, 
pretransfusion it was 1.92 ± 0.16min and  post transfusion 1.68 ± 0.06 
min.
Clotting  time  values   were  prehemodilution  4.12  ±  0.69min, 
posthemodilution 4.7 ± 0.86 min; pretransfusion 5.06 ± 0.04 min and post 
transfusion 4.90 ± 0.06 min.
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TABLE  14
CHANGES IN  BLEEDING TIME
Parameter Stages of ANH compared
Mean 
chang
e
P value
Prehemodilution vs postHemodilution 0.68 <0.05 S
Bleeding 
Time
Prehemodilution vs pretransfusion 0.86 <0.05 S
Prehemodilution vs posttransfusion 0.62 <0.001 S
S:Significant
       Table 14 gives the mean change and test of significance of bleeding 
time at various stages of ANH. Statistical analysis  of difference  between 
bleeding  time  during  different  stages  of  ANH  has  shown  to  be 
statistically significant with P value < 0.05 and < 0.001. But the values 
during different stages  were within normal clinical range.
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TABLE  15
CHANGES IN  CLOTTING TIME
Parameter Stages of ANH compared
Mean 
change
P value
Prehemodilution vs 
posthemodilution
0.62 <0.001 S
CLOTTING 
TIME
Prehemodilution vs 
pretransfusion
0.94 <0.0001 S
Prehemodilution vs 
posttransfusion
0.78 <0.0001 S 
S- Significant
Table 15 has given the mean change and test of significance of 
clotting time during various stages of ANH.
The changes in clotting time during different stages of ANH was 
statistically  significant  with  P<0.001 .  But  values  were  within normal 
physiological  limits .
TABLE  16
CHANGES IN HEMOGLOBIN  AND  HAEMATOCRIT 
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DURING ANH
Parameter
Pre 
Hemodilution
Post 
Hemodilution
Pre 
Transfusion
Post 
Transfusion
HB GMS% 12.16 ± 0.34 9.4 ± 0.5 8.20 ± 0.6 10.5 ± 0.8
HCT % 36.25 ± 2.6 28.0 ± 1.4 24.2 ± 1.9 32.8 ± 2.2
Hemoglobin in the prehemodilution period was 12.16 ±0.34 gm/dl, 
posthemodilution it was 9.4 ± 0.5 gm/dl, pretransfusion it was 8.2 ± 0.6 
gm/dl and posttransfusion  value was 10.5 ± 0.8 gm/dl.
Hematocrit values during different stages of acute normovolemic 
hemodilution  was  prehemodilution  36.25  ±  2.6% ;  posthemodilution  
27.8 ± 1.4%; pretransfusion 24.2 ± 1.9%  &  posttransfusion 32.8 ± 2.2%.
                                    
           
TABLE  17
CHANGES   IN   HB gms%   DURING   ANH
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Parameter Stages of ANH compared
Mean 
change
P value
Prehemodilution vs 
posthemodilution
2.76 <0.0001 S
HB gms %
Prehemodilution vs 
pretransfusion
3.96 <0.0001 S
Prehemodilution vs 
posttransfusion
1.66 <0.0001 S
S:Significant
Table   17  gives  the  mean  changes  and  test  of  significance  of 
Hemoglobin  at various stages of acute normovolemic hemodilution. The 
changes were found to be statistically significant.
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TABLE  18
HEMATOCRIT CHANGES DURING ANH
Parameter Stages of ANH compared Mean change P value
Prehemodilution vs 
posthemodilution
8.45 <0.0001 S
HEMATOCRIT 
%
Prehemodilution vs 
pretransfusion
12.05 <0.0001 S
Prehemodilution vs 
posttransfusion
3.45 <0.0001 S 
S:Significant
Table  18  gives  the  mean  change   and  test  of  significance  of 
Haematocrit at various stages of acute normovolemic hemodilution.
The  changes as anticipated were statistically significant.
TABLE  19
CHANGES IN RBC COUNT DURING ANH 
Parameter Pre Hemodilution
Post 
Hemodilution
Pre 
Transfusion
Post 
Transfusion
RBC COUNT 
(millions/ 
cumm)
4.65 ± 0.6 3.75 ± 0.3 3.3 ± 0.6 4.1 ± 0.3
The  red  blood  cell  count  during  different  stages  of  ANH was  
4.65 ± 0.6 million/cu.mm in  pre hemodilution period ; 3.75± 0.3 million/
cumm  during  posthemodilution;  3.3  ±  0.6  million/cumm  during 
pretransfusion and 4.1 ±0.3 million / cu.mm in the posttransfusion stage.
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TABLE  20
RBC COUNT CHANGES DURING ANH
Parameter Stages of ANH compared
Mean 
change
P value
Prehemodilution vs posthemodilution 0.9 <0.0001 S
RBC Count Prehemodilution vs pretransfusion 1.35 <0.0001 S
Prehemodilution vs posttransfusion 0.55 <0.0001 S 
S :Significant
Table 20 gives the mean change and test of significance of RBC 
count at various stages of Acute normovolemic hemodilution.
Following hemodilution the RBC count decreased to 3.75 ± 0.3 
millions  /  cumm,  during  pre  transfusion  period  the  values  further 
decreased to 3.3 ± 0.6 million /cu.mm, following transfusion the increase 
in RBC count was observed to reach values of 4.1 ± 0.3 million / cu.mm. 
The changes  were statistically significant as anticipated.
Table 21
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SURGICAL  BLOOD  LOSS
BLOOD  LOSS ANH  n=30
400-499 1  (3.3%)
500-599 2  (6.6%)
600-699 8  (26.6%)
700-799        11(36.6%)
800-899 6  (20%)
900-999 2  (6.6%)
36.6% patients had blood loss between 700 - 799 ml
26.6% patients had blood loss between 600 - 699 ml
20% had blood loss between 800 - 899 ml
6.6% had blood loss between 500 - 599 ml
Another 6.6% had blood loss between 900 - 999 ml
About 3.3% patients had blood loss between 400 - 499ml
Table 22
COST  ANALYSIS  OF  STUDY  REQUIREMENTS
ANH 
n=30
Blood 
volume 
collected 
(ml)
Colloid 
replaced 
(ml)
Cost 
Rs
Crystalloid 
replaced 
(ml)
Cost 
Rs
Sum 23400 15250 4713.6 36210 1975
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Average 780 508.3 157.1 1207 65.8
Venflon Blood bags used Cost ( Rs)
Total  Cost 
(Rs)
1650 80 6000 14338.6
55 2.6 195 472.9
Total volume of blood collected was 23400ml
Average volume of blood collected was 780ml.
Total colloid replaced was 15250ml
Average volume of colloid replaced was : 508.3 ml
508ml of colloid costed about : Rs.157
Total volume of crystalloid replaced was : : 36210ml
Average volume of crystalloid replaced was 1207ml
To replace 1207ml of crystalloid it costed : Rs.65.8
One 16G venflon used to withdraw blood costed :Rs.55.
The total no.of blood bags used was 80 on an average  the no.of blood  
bag used per patient was 2.6
The  blood  bags  used  for  blood  withdrawal  for  each  patient  
Costed:Rs165
The cost involved in withdrawing 780ml of blood was Rs.472.9
Therefore  to  withdraw  one  bag  of  350ml  of  blood  it  costs  : 
60
Rs.212.10 
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Table 23
Complications of ANH
Complications Pre Hemodilution Post Hemodilution
Pre 
Transfusion
Post 
Transfusions
Post 
Operative
Hypotension - - 1 - -
Oliguria - - - - -
Allergic reaction - 1 - - -
ST segment changes - - - - -
Pulmonary Odema - - - - -
Wound Infection - - - - 1
Urinary tract 
infection - - - - 1
In our study 1 patient experienced hypotension during the pretransfusion period .
Allergic reaction to colloid transfused  was noticed in 1 patient. During the postoperative period 1 patient had 
wound infection and one of the patient had urinary tract infection
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DISCUSSION
ANH is a safe ,easy to handle  and effective blood conservation 
technique. A number of studies conducted by comparing ANH with other 
blood conservation modalities in various surgical fields have confirmed 
this.
This  study  was  conducted  on  30  patients  undergoing 
gynaecological  surgeries  .Patients  were  monitored  intraoperatively, 
postoperatively for the various hemodynamic ,hematological parameters 
and for occurrence of complications.
Age distribution  :
In our study the age group of patients selected for the study were 
between 25-55 years with 33% of patients in the age group 35-39 years 
and 26%between  40-44 years  and 10% belonged  to  25-29 years  with 
6.6% of patients in both 45-49 and 50-54 year age group.
KUMAR  et  al(28) conducted  a  study  of  ANH  on  patients 
undergoing general,ENT and orthopedic surgeries.The mean age of the 
patients  entering  the  study  was  39+15  years  i.e.24-54  years.It  was  a 
comparative  study  between  Acute  normovolemic  hemodilution  and 
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Hypervolemic  hemodilution.55%  patients  belonged  to  35-45  year  age 
group. 35% belonged to 24-35 year age group.5% belonged to45-50 years 
and 5% were >50 years.
          GOKHALE  and  PS ROY et al (9) conducted a study comparing 
the efficacy between Preoperative autologous blood donation and acute 
normovolemic  hemodilution,  on  patients  undergoing  general  and 
gynaecological surgeries.
The age group of patients selected were between 21-60 years.46% 
of patients belonged to 41-50 year age group.32%belonged to 31-40 year 
age group.5% of them belonged to 51-60 year age group, remaining 17% 
belonged to 21-30 year age group.
The age group of patients selected for our study on ANH is similar 
to the age group of patients selected for the above 2 studies.
Weight of the patients :
In the study conducted by  Mirhasemi et al(29) by comparing the 
two diluents HES and 5% Dextran used for ANH on patients undergoing 
major  gynaecological  surgeries  the  mean  weight  of  the  patients  was 
56+8kg.
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 In  the  study  by  KUMAR  et  al(28) who  compared  between 
Hypervolemic  hemodilution  and  Isovolemic  hemodilution  on  patients 
undergoing general ,ENT and orthopedic surgeries the mean weight of 
patients was 53+9 kg.
In our study the mean weight of our patients was 58+6 kg.
The weight of the patients who underwent ANH in our study is 
similar to those included in the above 2 studies.
Hematocrit :
NESS et al conducted  a study  comparing  perioperative moderate 
hemodilution with  preoperative autologous blood  donation .The mean 
hematocrit of  patients  included in  the  ANH  group was  34.8+4.7%.
In  KUMAR et al(28) study which was done on patients undergoing 
general and ENT surgeries the mean hematocrit among  the ANH group 
was 32.1+2.4%.
The average initial hematocrit of patients included in our study was 
36.25%.
This   value  of  hematocrit  for  our  patients  was  similar   to   the 
hematocrit values of patients included  for the above 2 studies.
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Heart  rate :
In the study conducted by  Good nough LT et al(23) by performing 
moderate   Acute  Normovolemic  Hemodilution  on  patients  undergoing 
total  hip replacement,  baseline  heart  rate  was   76+14 beats  /min,after 
withdrawal of  first   unit  of  blood it  was 72+11 beats /min and after 
collection  of  second unit  it  was 74+12 beats/min. The change in heart 
rate in his study was statistically insignificant..
SUTTNER et al(33) conducted a study comparing the blood sparing 
efficacy  of  controlled hypotension alone with combination of ANH and 
controlled hypotension .In the later group after hemodilution the baseline 
HR was 72 beats/min,Intraoperative 68/min and immediate postoperative 
period  it  was  73  beats  /min.Heart  rate  change  was  not  statistically 
significant during various phases of ANH.
In a study by KLOEVEKORN  W.P. et al where moderate acute 
normovolemic hemodilution was done to a target haematocrit of 27+1 % 
heart rate was not changed significantly.
In  our  study the baseline  heart  rate  was  77.4+5beats/min  .After 
hemodilution 78+5/min,pretransfusion it was 79.2+5 and posttransfusion 
79.6+4/min.The difference was not statistically significant during various 
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phases of ANH which is concurrent to the above 3 studies.
BLOOD  PRESSURE  :
In our study MeanArterial Pressure in the prehemodilution period 
was  94.7+6  mm  Hg.Posthemodilution   period  it  was  93.3+5  mm 
Hg.During the pretransfusion period mean arterial pressure was 92.57+ 
0.8  mm  Hg  and  in  the  post  transfusion  period  it  was  94.2+5   mm 
Hg.Throughout  the  phases  of  ANH  the  blood  pressure  changes  were 
statistically insignificant.
Hillel  laks et  al(17) performed   normovolemic  hemodilution   in 
patients  undergoing total hip replacement. Baseline BP was 122 /78 mm 
Hg ,post dilution it was 115/76 mmHg,intraoperative it was 115/80 mm 
Hg.Post transfusion was 119/76 mm Hg.The changes in Blood pressure 
were statistically  insignificant throughout.
In Anish Firodiya et al(2) study of  ANH  on  cancer patients the 
values  of  Mean  Arterial  Presssure  were  as  follows  Prehemodilution 
98.24+4.89 mm Hg,Posthemodilution 95.68+7.1 mm Hg.This difference 
was statistically significant  but  clinical difference was only 3 mm Hg 
and insignificant. The mean postoperative values of MAP  was 95.86+.07 
mm Hg, which was statistically insignificant.(P>0.05)
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The observation in our  study is similar to the results of the above 
studies.
OXYGEN  SATURATION :
In   the study  of  moderate   acute   normovolemic   hemodilution 
performed  on  patients  undergoing  primary  total  hip  arthroplasty  by 
Goodnough  LT  et  al(23) the  oxygen  saturation  was  99+2  %  in  the 
prehemodilution  period  and  99+1%  after  withdrawal  of  2  units  of 
blood  .The  difference  in  the  saturation  levels  were  statistically 
insignificant.
John  L  Fontana  et  al(21) in  their  study  on  acute  profound 
normovolemic hemodilution during during scoliosis surgery found that 
PaO2 during  various  phases  was  505.9+81.7  prehemodilution.; 
posthemodilution it was 496+55.6 and posttransfusion 520.1+75.5. There 
was  no  statistical  difference   among  the  saturation  levels  of  various 
phases.
In  a  study by  SUTTNER et  al(33) comparing  the  blood sparing 
efficacy of controlled hypotension with combined Acute Normovolemic 
Hemodilution and controlled hypotension  the paO2 values during various 
phases  was  baseline  169  mm  Hg,  Posthemodilution  155mm  Hg  and 
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posttransfusion 153mm Hg which was statistically insignificant.
In  our  study  the  oxygen  saturation  during  prehemodilution  was 
99.5+0.08,  Posthemodilution  it  was  99.6+0.4,  Pretransfusion  it  was 
99.43+6, Posttransfusion value was 99.5+0.09. There was no statistical 
difference between the values.
         This is concurrent to the above  3 studies.
Bleeding time and  Clotting time :
Stephanie  B  Jones et  al(34) conducted   acute  normovolemic 
hemodilution on 40 patients undergoing radical prostatectomy. They used 
4  different  diluents  RL,5%  albumin,  6%  Dextran,  6%  Hetastarch  to 
compare their influence on hemostatic markers.
The difference between the preoperative and postoperative values 
of  bleeding  time  were  statistically  significant  in  all  group  of  patients 
except when RL was used as diluent.
     Prehemodilution,  posthemodilution  and  postoperative  values  of 
clotting time was statistically significant in all patients  irrespective of the 
diluent used.
In  our  study  the  prehemodilution  bleeding  time  was  1.06+0.16 
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minutes, posthemodilution 1.74+0.04 min, pretransfusion 1.92+0.16 min, 
posttransfusion 1.68+0.06 min which were statistically  significant.  But 
the mean  values were  within  physiologically  normal limits.
       The  prehemodilution  clotting  time  was  4.12+0.69  minutes, 
posthemodilution  was  4.74  + 0.86  min;  pretransfusion  5.06+0.04min; 
posttransfusion 4.9+0.04min.The difference was statistically significant. 
But  the  mean  values  were  within  the  clinical  normal  limits.  So  this 
observation is similar to the above study.
Messmer, Sunderplassmann et al  showed in their studies , blood 
coagulation was not impaired as long as the hematocrit is above 20%.
HEMOGLOBIN :
In  their  study  Stephanie  B.Jones et  al(34) observed  that  mean 
Hemoglobin values were 12.5±0.8 gm/dl prehemodilution ;9.2±0.6 gm/dl 
posthemodilution; and 10.2±1 gm/dl in the postoperative period. This was 
statistically significant.
Suttner  et  al(33)  in  their  study  observed  following  Hb  levels 
changes  Baseline  13.7  gm/dl;  posthemodilution  9.1  gm/dl; 
posttransfusion 9.7gm/dl.The difference was statistically significant.
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In our study the Hb levels were 12.16±0.34gm/dl prehemodilution; 
9.4±0.5gm/dl  posthemodilution;  8.2±0.6gm/dl  pretransfusion,  10.5±0.8 
gm/dl posttransfusion. The difference between the values is statistically 
significant, which is similar to the above studies.
HEMATOCRIT :
In  their  study   Hillel  Laks  et  al(17) observed  that  baseline 
hematocrit was 42%, posthemodilution it was 21.3% after withdrawal of 
2 units of blood; pretransfusion it was 19.7%; posttransfusion was 25.7%.
KLOEVEKORN  W.P  et  al in  their  study  of  moderate  acute 
normovolemic  hemodilution  observed  that  prehemodilution  hematocrit 
was 38 %; post hemodilution it was 31%, pretransfusion 27% and during 
posttransfusion it was 29% .The differences were statistically significant.
In  our  study  the  prehemodilution   Hematocrit  is  36.25±2.6% 
posthemodilution  Hematocrit  is  27.8±1.4%,  pretransfusion  24.2±1.9% 
and posttransfusion was 32.8±2.2%. The  differences were statistically 
significant which is concurrent with the above studies.
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RED CELL COUNT  :
In  our  study the RBC count  was  4.65±0.6 millions/mm3 in the 
prehemodilution period, 3.75±0.3 million/mm3 in the posthemodilution 
period  3.3±0.6millions/mm3  in  pretransfusion  period  4.1±0.3 
millions/mm3 in posttransfusion period. The difference in RBC count as 
anticipated was statistically significant.
COST  FACTOR : 
In our study the average volume of blood collected was 780 ml per 
patient.  .Colloid  used  for  replacement  was  508ml  and  costed 
Rs.157.10.Average volume of crystalloid used was 1207 ml and costed 
Rs 65.80. Average number of blood bags used was 2.6 per patient and 
costed  Rs.195  .  16G  venflon  used  for  blood  withdrawal  costed 
Rs.55.Total  cost   was  Rs.472.90  on  an  average  for  one  patient.  For 
withdrawal of one bag   of  350 ml of blood it costs Rs.210.10.
The major proportion of the cost incurred was spent on the blood 
bags .Colloids constitute for the next major proportion of money spent. 
Crystalloids and venflon consumed a small proportion of the total cost. 
Among them the cost of blood bags will be incurred when the patient 
needs homologous blood during surgery too. Thus we find that the cost 
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incurred for Acute Normovolemic Hemodilution is reasonable compared 
with  the  expense  involved  in  collection,  screening,  storage  and 
crossmatching needed for homologous blood.
TIME  FACTOR :
Average blood collected in our  study was 780 ml/patient  and it 
took 45 minutes for hemodilution.For collecting 1 unit of 350 ml of blood 
time taken was 20.1 minutes.
COMPLICATIONS :
In  our  study 1 patient  among 30 patients  who underwent  ANH 
experienced  hypotension  with  systolic  BP<  100  mm  Hg  during 
pretransfusion  period  ;  the  blood  pressure  was  stabilized  after 
administration  of   1  unit  of  RL  and  starting  collected  blood 
simultaneously through other port.
In a study by DOMEN et al(13) who evaluated the adverse effects 
of  autologous  blood  in  patients  undergoing  major  general  surgeries 
hypotension occurred in 2 patients among 68 who underwent ANH.
The results of our study is similar to the above study.
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In  our  study  one  patient  developed  allergic  reaction  to  colloid 
administered.  J.RING  et  al  has  reported   the  incidence  of  adverse 
reaction to colloid to be 10-20/10000 patients. His observation therefore 
coincides with our study.
The  incidence  of  wound  infection  in  our  study  is  1  among  30 
patients who underwent ANH.
In a study conducted by SANDERS et al(31) ANH in patients under 
going major GI surgeries the incidence of wound infection was 3 among 
78 patients.
The  incidence  of  urinary  tract  infection  postoperatively  was  1 
among 30 patients in our study. In SANDERS et al31 study the incidence 
of UTI was 5 among 78 patients who underwent ANH during major GI 
surgeries.
So the results of our study  is  concurrent  to the findings in the 
above study.
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SUMMARY
In  our  study  on  Acute  Moderate  Normovolemic  Hemodilution 
carried  out  on  patients  undergoing  gynaecological  surgeries  we  found 
that,
 Average  blood  collected  was  780  ml  per  patient  ,the  average 
volume  of  colloid  used  was  508  ml  and  average  volume  of 
crystalloid used was 1207 ml.
 Average time taken to collect 780 ml of blood was 45 min.
 The changes in Heart rate,systolic blood pressure, diastolic blood 
pressure  and  mean  arterial  pressure  in  the  prehemodilution, 
posthemodilution,  pretransfusion,  posttransfusion  periods  were 
statistically  insignificant.All  the  parameters  were  well  within 
physiological limits throught the procedure.
 Oxygen  saturation  changes  during  the  prehemodilution, 
posthemodilution,  pretransfusion,  and posttransfusion period was 
statistically insignificant.
 Bleeding time and clotting time changes during prehemodilution, 
posthemodilution, pretransfusion, and posttransfusion period were 
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statistically  significant  but  the  changes  were  clinically 
insignificant.
 Acute  Normovolemic  Hemodilution  was  technically  easy  to 
perform. 
 Hemoglobin, Hematocrit and Red blood cell count dropped after 
hemodilution  and  following  surgical  blood  loss  they  further 
dropped  down.The  values  rose  up  after  transfusion  of  collected 
autologous blood.
 The  complications  observed  during  the  study  were  hypotension 
1/30,allergic reaction to colloid in1/30 wound infection 1/30 and 
urinary tract infection in 1/30.
 The average cost incurred per patient for withdrawal of 780 ml of 
blood was Rs472.9 which accounts for Rs 210.10 per 350 ml bag 
of blood.
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CONCLUSION
From  the  observation  we  can  conclude  that  moderate  Acute 
Normovolemic Hemodilution is a safe ,technically easy,relatively cheaper 
method  to  be  considered  for  salvaging  homologous  blood  transfusion 
during gynaecological surgeries.Elaborating it
• Acute  Normovolemic  Hemodilution  can  be  safely  performed on 
patients  with  routine  monitoring  of  Heart  rate,Blood  pressure, 
Pulse oximetry, Urine output and ECG changes.
• It  avoids  the  complications  of  transfusion  reactions  and 
transmission  of  infectious  diseases  associated  with  homologous 
blood transfusion.
• It  is  a  cost  effective  method  to  overcome  the  shortage  of 
homologous bank blood.
• The technique of Acute Normovolemic Hemodilution is relatively 
easy to carry out but can extend the theatre occupancy time by an 
average of 20.1 minutes for each 350ml of blood withdrawn.
• The  complications  related  to  the  procedure  are  minimal  when 
compared with the benefits.
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PROFORMA
ACUTE NORMOVOLEMIC HEMODILUTION
Name : Age : Unit : I.P. No.
Weight : Date of 
Surgery: 
Diagnosis :
Surgery :
INVESTIGATIONS
1. Hb : BT :
2. PCV : CT :
3. T.C., DC, ESR : Blood group :
4. RBC count : Chest X-Ray :
5. Platelets : ECG :
6. Blood - Urea : Urine Alb :
  Sugar : Sugar :
7. Sr. Creatinine : Microscopy :
8. Sr.Electrolytes Na+ :
K+ :
9. S.proteins :
FORMULA : Volume of Blood to be removed 
= EBV x 
(HCT Initial - HCT Target)
HCT Average
Volume of blood withdrawn : Fluids Replaced :
Colloids :
Crystallodis :
Anesthetic Technique : Starting time :
Monitoring : Completing time :
Pre ANH Post ANH Pre 
Transfusion
Post 
Transfusion
H.R.
S.B.P.
D.B.P.
SPO2
Urine Output
ECG changes
Pre 
ANH
Post 
ANH
Pre 
Transfusion
Post 
Transfusion.
Hb (gm/dl)
HCT (%)
BT (minutes)
CT (minutes)
RBC Count 
(Millions / cumm)
Initial 
Hb %
Initial 
HCT 
%
Target 
HCT 
%
Max 
volume of 
blood that 
can be 
withdrawn
Volume 
of blood 
collected 
ml
Colloid 
Replaced 
ml
Crystalloid 
Replaced 
ml
Surgical Blood Loss : First Post Operative day. :   Hb :        PCV :
Date of discharge :   Hb :        PCV :
Intraoperative : Any complication :
Complications In postoperative
Period
ABBREVIATION
ANH - Acute Normovolemic Hemodilution
BT - Bleeding Time
CT - Clotting  Time
DBP - Diastolic Blood Pressure
DPG - DiPhospho Glycerate
ECG - Electro Cardiogram
EDRF - Endothelium Derived  Relaxing Factor
ESR - Erythrocyte Sedimentation Rate
gms - Grams
HES - Hydroxy Ethyl Starch
Im - Intramuscular
Iv - Intra venous
Inj - Injection
IP No - Inpatient Number
min - Minutes
mcg - Microgram
MAP - Mean Arterial Pressure
NS - Normal Saline
PABD - Preoperative Autologous  Blood Donation
PCV - Packed Cell Volume
RL - Ringer Lactate
RBC - Red Blood Corpuscle
Sr - Serum
SBP - Systolic Blood Pressure
Spo2 - Saturation of oxygen
Pao2 - Arterial oxygen saturation
Tab. - Tablet
U.O - Urine Output
